Reshma Rangwala - EVP & Chief Medical Officer at Karyopharm Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP & Chief Medical Officer
Stock Symbol
KPTI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Reshma Rangwala - trading volume in the past year for Karyopharm Therapeutics Inc.

Holdings reported by Reshma Rangwala for Karyopharm Therapeutics Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common 350K $420K $1.20 Mar 1, 2024 Direct
Common Stock 343K $401K $1.17 Apr 22, 2024 Direct

Transactions reported by Reshma Rangwala for Karyopharm Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.